We are live on
!
Find out more
Atossa Therapeutics
ATOS
ATOS
10 hedge funds and large institutions have $472K invested in Atossa Therapeutics in 2017 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
55% more capital invested
Capital invested by funds: $305K → $472K (+$167K)
0.01% more ownership
Funds ownership: 0.06% → 0.07% (+0.01%)
17% less funds holding
Funds holding: 12 → 10 (-2)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Holders
10
Holders Change
-2
Holders Change %
-16.67%
% of All Funds
0.25%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
4
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$166K |
| 2 |
Renaissance Technologies
New York
|
+$128K |
| 3 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$15.1K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.29K |
| 5 |
VKH
Virtu KCG Holdings
New York
|
+$2.16K |
Top Sellers
| 1 |
Citadel Advisors
Miami,
Florida
|
-$9K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$3.91K |
| 3 |
Barclays
London,
United Kingdom
|
-$2K |